| Views | |
|---|---|
| Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells | 98 |
| March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | |
|---|---|---|---|---|---|---|---|
| Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells | 5 | 4 | 12 | 3 | 3 | 1 | 1 |
| Views | |
|---|---|
| 2022_Berlak_etal.pdf | 31 |
